Molekuláris változások a szignáltranszdukciós útvonalakban praeeclampsiában és HELLP szindrómában [PDF]
, 2017 Csörgőné Szabó, Szilvia
core +1 more source
Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis [PDF]
, 2015 Bao-guo Dong +3 more
core +1 more source
Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx [PDF]
, 2014 core +1 more source
Liver diseases such as liver cirrhosis, primary and metastatic liver cancers are still a major medical challenge. Syndecan-1 is one of the most important proteoglycans in the liver. Syndecan-1 is normally expressed on the surfaces of hepatocytes and cholangiocytes. Due to liver diseases the amount of syndecan-1 increases in the liver.
Regős E +6 more
openaire +1 more source
Syndecan-1 as a Biomarker for Cardiovascular Risk in Patients with Behçet's Disease. [PDF]
Arch RheumatolKadıyoran C +6 more
europepmc +1 more source
Maternal plasma syndecan-1: a biomarker for fetal growth restriction. [PDF]
J Matern Fetal Neonatal Med, 2023 Juusela A +10 more
europepmc +1 more source
Early plasma syndecan-1 dynamics and their prognostic value in major thoracic and abdominal surgery: a prospective observational study. [PDF]
Perioper Med (Lond)Laurens LM +5 more
europepmc +1 more source
Association Between Serum Syndecan 1 Levels and Metabolic Syndrome Parameters: A Comparative Cross-Sectional Study. [PDF]
Endocrinol Diabetes MetabTavalaie S +9 more
europepmc +1 more source
The Intensity and Pattern of Syndecan-1 (CD138) Expression in Normal and Diseased Livers. [PDF]
Cureus, 2023 Atique M +4 more
europepmc +1 more source
Targeting Prostate Cancer Cells Using Anti-Sortilin and Anti-Syndecan-1 Antibody Drug Conjugates. [PDF]
Int J Mol SciLi KL +9 more
europepmc +1 more source